TheEdgeResearch
Home / Stocks / VIVXF

Avivagen Inc. (VIVXF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$7,769
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.35
52-Wk Range
0.0001-0.0012
CEO
G. F. Kym Anthony
Country
CA
Currency
USD

Avivagen Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ottawa, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $7,769. On trailing twelve-month figures it carries a trailing P/E of -0.11, a net margin of -645.9%. Its beta of 0.35 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.11
Price / Sales
0.83
Price / Book
-0.11
EV / EBITDA
-2.69
Gross margin
42.6%
Operating margin
-99.4%
Net margin
-645.9%
Return on equity
—
Debt / equity
-1.02
Current ratio
0.61
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
13
IPO date
2013-05-02
Headquarters
Ottawa, ON, CA
About Avivagen Inc.

Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity. The company's diverse product lineup features OxC-beta Livestock, a crucial premix for farm animal diets. Beyond agriculture, Avivagen also manufactures health supplements such as Vivamune and Dr. Tobias-branded chews for dogs, along with the Dr. Tobias Beta blend, formulated to support human immunity. Established in 2005 and based in Ottawa, Canada, Avivagen Inc. distributes its offerings across numerous international markets, including the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia.

Comparable companies

Avivagen Inc. is most often compared with the following Healthcare names:

AOXGCNNXFCWWBFFFNTFGBHPFHMPQINSOPZOORLBDVDRM
More research on VIVXF
VIVXF technical analysis VIVXF TheEdge Score Compare against peers
Open full interactive analysis & DCF →